What Is Parkinson’s Disease? Neuropathology, Neurochemistry, and Pathophysiology

Hurtig, Howard

doi:10.1007/978-1-59259-410-8_3

Howard Hurtig MD

Part of the book series: Current Clinical Practice ((CCP))

557 Accesses
1 Citations

Abstract

Idiopathic parkinsonism, or Parkinson’ s disease (PD), is a neurodegenerative disorder of middle and late life with a well-defined morbid anatomy, a specific pattern of biochemical pathology, and an unknown cause. Its name immortalizes Dr. James Parkinson, the British physician whose classic 1817 monograph, Essay on the Shaking Palsy, is unrivaled as a lucid and timeless description of the cardinal symptoms and signs of what is now recognized as one of the most common neurologic disorders in the Western world.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Chapter: USD 29.95; Price excludes VAT (USA)

eBook: USD 229.00; Price excludes VAT (USA)

Softcover Book: USD 299.99; Price excludes VAT (USA)

Hardcover Book: USD 299.99; Price excludes VAT (USA)

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Selected Reading

Gibb WRG, Lees AJ. Pathological clues to the cause of Parkinson’ s disease, in Movement Disorders(Marsden CD, Fahn S eds), 3rd ed, Butterworth-Heinemann, Oxford, 1994, pp. 147–166.
Google Scholar
Marsden CD. Neurophysiology, in Parkinson’s Disease( Stern GM ed), Johns Hopkins University Press, Baltimore, 1990, pp. 57–98.
Google Scholar
Marsden CD. The mysterious motor function of the basal ganglia: the Robert Wartenberg Lecture. Neurology 1982; 32: 514–539.
Article PubMed CAS Google Scholar
Stern MB. Contemporary approaches to the pharmacotherapeutic management of Parkinson’s disease: an overview. Neurology1997; 49 Suppl 1: S2 - S9.
Article PubMed CAS Google Scholar
Uhl GR. Hypothesis: the role of dopaminergic transporters in selective vulnerability of cells in Parkinson’s disease. Ann Neurol1998; 43: 555–560.
Article PubMed CAS Google Scholar
Wichmann T, DeLong MR. Physiology of the basal ganglia and pathophysiology of movement disorders of basal ganglia origin, in Movement Disorders: Neurologic Principles and Practice( Watts RL, Koller WC eds), McGraw-Hill, New York, 1997, pp. 87–97.
Google Scholar

Download references

Authors

Howard Hurtig MD
View author publications
You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

Parkinson’s Disease and Movement, Disorders Center, Department of Neurology, Mayo Clinic Scottsdale, Scottsdale, AZ, USA
Charles H. Adler MD, PhD (Consultant and Co-Director, Associate Professor of Neurology) (Consultant and Co-Director, Associate Professor of Neurology)
Mayo Medical School, Rochester, MN, USA
Charles H. Adler MD, PhD (Consultant and Co-Director, Associate Professor of Neurology) & J. Eric Ahlskog PhD, MD (Chair, Consultant, Professor of Neurology) (Consultant and Co-Director, Associate Professor of Neurology) & (Chair, Consultant, Professor of Neurology)
Division of Movement Disorders, Department of Neurology, Mayo Clinic Rochester, Rochester, MN, USA
J. Eric Ahlskog PhD, MD (Chair, Consultant, Professor of Neurology) (Chair, Consultant, Professor of Neurology)

Rights and permissions

Reprints and permissions

Copyright information

About this chapter

Cite this chapter

Hurtig, H. (2000). What Is Parkinson’s Disease? Neuropathology, Neurochemistry, and Pathophysiology. In: Adler, C.H., Ahlskog, J.E. (eds) Parkinson’s Disease and Movement Disorders. Current Clinical Practice. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-410-8_3

Download citation

DOI: https://doi.org/10.1007/978-1-59259-410-8_3
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-095-3
Online ISBN: 978-1-59259-410-8
eBook Packages: Springer Book Archive

Publish with us

Policies and ethics